MetaCap

Beam Therapeutics Statistics

NASDAQ: BEAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

20.90-0.04 (-0.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Beam Therapeutics by the numbers

Beam Therapeutics has a market capitalization of $2.16 billion based on 103.50M shares outstanding. With trailing EPS of $-0.87, Beam Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.2% below its 50-day average and 24.6% below its 200-day average.

Average daily trading volume is 2.04M shares, or about $42.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BEAM valuation vs. peer median

BEAM compared with the median of 8 peer companies
MetricBEAMPeer medianDifference
Market cap$2.16B$1.72B+26%
Avg. volume2.04M1.79M+14%

Peer median across 8 companies: BCRX, COAG, REPL, LYCA, MAZE, VIR, RXRX, ALVO.

Valuation

Price / sales (latest FY)
15.48
EPS (TTM)
$-0.87

Price and trading

Previous close
20.94
Open
20.54
Day range
20.54 – 22.10
52-week range
20.44 – 38.26
52-week change
-5.90%
Beta
—
Volume
3.88M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
2.16B
Forward Pe
-4.05
Eps
-0.87
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
38.26
Week52 Low
20.44
Avg Volume
2.04M
Shares Outstanding
103.50M
Ma50
24.63
Ma200
27.72
Earnings Date
Nov 3, 2026
Pct From52w High
-45.37%
Pct From52w Low
2.25%

Related